Kymera Therapeutics Ownership | Who Owns Kymera Therapeutics?
Kymera Therapeutics Ownership Summary
Kymera Therapeutics is owned by 54.71% institutional investors, 2.26% insiders, and 43.03% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 8.27% of KYMR shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.46% of its assets in Kymera Therapeutics shares.
KYMR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kymera Therapeutics | 54.71% | 2.26% | 43.03% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 6.65M | 8.27% | $376.47M |
| Avoro capital advisors | 6.35M | 7.89% | $359.41M |
| Fmr | 5.88M | 7.31% | $332.79M |
| Vanguard group | 6.27M | 7.18% | $487.69M |
| Bvf inc/il | 5.50M | 6.84% | $311.45M |
| Wellington management group llp | 5.20M | 6.46% | $294.08M |
| Price t rowe associates inc /md/ | 5.10M | 6.34% | $288.51M |
| Atlas venture life science advisors | 4.90M | 6.09% | $277.14M |
| Blackrock | 4.16M | 5.87% | $124.04M |
| Blackrock funding, inc. /de | 5.00M | 5.73% | $389.37M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atlas venture life science advisors | 4.90M | 36.82% | $277.14M |
| Merck | 772.16K | 19.17% | $43.70M |
| Bvf inc/il | 5.50M | 12.63% | $311.45M |
| Siren | 3.43M | 7.59% | $194.03M |
| Aquilo capital management | 138.52K | 6.80% | $3.79M |
| Aju ib investment | 19.65K | 6.71% | $1.53M |
| Boxer capital management | 319.10K | 5.76% | $18.06M |
| Avoro capital advisors | 6.35M | 4.65% | $359.41M |
| Monashee investment management | 100.00K | 4.38% | $7.78M |
| Foresite capital management vi | 146.33K | 3.20% | $8.28M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 6.27M | 0.01% | 845.92K |
| Holocene advisors, lp | 840.33K | 0.11% | 840.33K |
| Blackrock funding, inc. /de | 5.00M | 0.01% | 638.65K |
| Alyeska investment group | 615.09K | 0.11% | 565.09K |
| T. rowe price investment management | 611.22K | 0.02% | 520.59K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 5.10M | 0.03% | -1.76M |
| Redmile group | - | - | -803.29K |
| Deep track capital, lp | - | - | -600.33K |
| Jennison associates | 496.67K | 0.02% | -531.07K |
| Avidity partners management lp | - | - | -500.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Holocene advisors, lp | 840.33K | 0.11% | 840.33K | $47.56M |
| First turn management | 277.73K | 2.36% | 277.73K | $15.72M |
| Braidwell lp | 276.69K | 0.46% | 276.69K | $15.66M |
| Logos global management lp | 250.00K | 1.27% | 250.00K | $14.15M |
| Timessquare capital management | 189.90K | 0.22% | 189.90K | $14.78M |
Sold Out
| Holder | Change |
|---|---|
| Global financial private client | -1.00 |
| Financial gravity asset management | -2.00 |
| Capital performance advisors llp | -3.00 |
| Wealthspire advisors | -5.00 |
| Principal securities | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 177 | -17.67% | 47,762,207 | -40.94% | 54 | 0.64% | 117 | -4.10% | 37 | -31.48% |
| Sep 30, 2025 | 208 | -0.95% | 79,891,044 | 2.85% | 99 | 1.07% | 117 | -10.00% | 53 | 6.00% |
| Jun 30, 2025 | 215 | 18.78% | 78,776,956 | 8.20% | 97 | 1.19% | 132 | 48.31% | 52 | -7.14% |
| Mar 31, 2025 | 20 | -89.07% | 22,191,205 | -69.06% | 27 | 0.31% | 7 | -92.39% | 4 | -93.10% |
| Dec 31, 2024 | 180 | -0.55% | 71,156,642 | 3.18% | 93 | 1.14% | 88 | -4.35% | 59 | -4.84% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 2.24M | 3.46% | 52.60K |
| Fidelity Growth Compy Commingled Pl S | 2.82M | 3.46% | 397.01K |
| Vanguard Health Care Inv | 2.17M | 2.66% | -215.16K |
| Vanguard Total Stock Mkt Idx Inv | 2.12M | 2.60% | 5.95K |
| Fidelity Growth Company Fund | 2.03M | 2.48% | 348.97K |
| T. Rowe Price New Horizons | 1.97M | 2.41% | 177.21K |
| US Small-Cap Growth II Equity Comp | 1.97M | 2.41% | 116.38K |
| Vanguard US Total Market Shares ETF | 1.54M | 2.38% | 1.91K |
| Vanguard Small Cap Index | 1.52M | 1.86% | -65.00 |
| American Funds SMALLCAP World A | 1.39M | 1.70% | 276.47K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 11, 2026 | Chadwick Jeremy G | Chief Operating Officer | Sell | $930.21K |
| Mar 11, 2026 | Chadwick Jeremy G | Chief Operating Officer | Sell | $1.07M |
| Mar 11, 2026 | Chadwick Jeremy G | Chief Operating Officer | Sell | $144.96K |
| Mar 04, 2026 | Chadwick Jeremy G | Chief Operating Officer | Sell | $33.09K |
| Mar 02, 2026 | Chadwick Jeremy G | Chief Operating Officer | Sell | $33.90K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 36 |
| 2025 Q4 | 2 | 38 |
| 2025 Q3 | - | 2 |
| 2025 Q2 | 7 | 7 |
| 2025 Q1 | - | 9 |
KYMR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools